Cellebrite, Blackback Technologies offerings, product demos, materials, presentations (Drug Enforcement Administration)

Christopher Bing filed this request with the Drug Enforcement Administration of the United States of America.
Tracking #

20-00422-F

Multi Request Cellebrite, Blackback Technologies offerings, product demos, materials, presentations
Due June 22, 2020
Est. Completion None
Status
Awaiting Response

Communications

From: Christopher Bing


To Whom It May Concern:

Pursuant to the Freedom of Information Act, I hereby request the following records:

Product brochures, Powerpoint presentations, memos, emails and other documents from technology contractor Cellebrite and its subsidiary Blackbag Technologies Inc. about their offerings. Such product documents may carry terminology/keywords/descriptions that include: "Digital Intelligence Solutions," "forensic acquisition," "UFED" and "digital investigations." This FOIA seeks marketing, training and other related materials produced by the contractor, Cellebrite/BlackBag Technologies, to explain/sell their product offerings/services to U.S. government national security and law enforcement agencies/offices between the years 2017 and 2020 (or date of review). Cellebrite and Blackbag Technologies products help customers access data on electronic devices, including for "Windows, macOS, iOS and Android-based" systems. Cellebrite acquired Blackbag Technologies in 2020; this requests individually asks for documents pertaining to either/both companies from both before and after the acquisition.

Cellebrite is an Israeli company that manufactures data extraction, transfer and analysis devices for cellular phones and mobile devices. The company is a subsidiary of Japan's Sun Corporation. Blackbag Technologies Inc., a U.S.-based Cellebrite company, provides forensic solutions for Windows, Mac, iPhone and Android devices.

The requested documents will be made available to the general public, and this request is not being made for commercial purposes.

In the event that there are fees, I would be grateful if you would inform me of the total charges in advance of fulfilling my request. I would prefer the request filled electronically, by e-mail attachment if available or CD-ROM if not.

Thank you in advance for your anticipated cooperation in this matter. I look forward to receiving your response to this request within 20 business days, as the statute requires.

Sincerely,

Christopher Bing

From: Drug Enforcement Administration

Good morning,

Please see the attached acknowledgement letter regarding your FOIA case number 20-00422-F.

If you have any additional question please contact our customer service hotline at 202-307-7596.
Best,

Yvette Davis
Program Analyst
Freedom of Information and Records Management Section
Office of Administration

From: Drug Enforcement Administration

Good Morning Mr. Bing -

Please see the attached status update of your request.

Respectfully,

Cynthia Chasten, GIS Specialist
FOI/Records Management Section
8701 Morrissette Drive
Springfield, Virginia 22152
202-307-7615

From: Drug Enforcement Administration

Good Morning Mr. Bing -

Please see the attached status update of your request.

Respectfully,

Cynthia Chasten, GIS Specialist
FOI/Records Management Section
8701 Morrissette Drive
Springfield, Virginia 22152
202-307-7615

From: Drug Enforcement Administration

Good Morning -

Please be advised, due to the national emergency concerning the novel coronavirus disease (COVID-19) outbreak, DEA, like many federal agencies, has mandated telework for its FOIA staff. As a result, you may experience a delay in receiving a substantive response to your FOIA request. DEA will finish processing your request as quickly as possible at the resolution of the COVID-19 emergency.

Your patience in this matter is appreciated and no further clarification is needed.

V/R
Cynthia Chasten, GIS Specialist
FOI/Records Management Section
8701 Morrissette Drive
Springfield, Virginia 22152
202-307-7615

From: Drug Enforcement Administration

Good Morning,

This email is in response to your recent inquiries regarding the status of your pending Freedom of Information/Privacy Act request. As you are aware, due to the national emergency concerning the novel coronavirus disease (COVID-19) outbreak, DEA, like many Federal Agencies, has mandated telework for its FOIA staff. As a result, you may experience a delay in receiving a substantive response to your FOIA request. Please be assured that your request will be processed as expeditiously as possible.

Thank you for your patience in this matter and no further clarification is needed.

V\R

Cynthia Chasten, GIS Specialist
FOI/Records Management Section
8701 Morrissette Drive
Springfield, Virginia 22152
202-307-7615

From: Drug Enforcement Administration

Good Morning -

Please be advised, our office is currently reviewing documents related to your request. As you are aware, due to the national emergency concerning the novel coronavirus disease (COVID-19) outbreak, DEA, like many Federal Agencies, has mandated telework for its FOIA staff. As a result, you may experience a delay in receiving a substantive response to your FOIA request. DEA will finish processing your request as quickly as possible.

Your patience in this matter is appreciated.

Cynthia Chasten, GIS Specialist
FOI/Records Management Section
8701 Morrissette Drive
Springfield, Virginia 22152
202-307-7615

From: Drug Enforcement Administration

Good morning Mr. Bing:

Please see the attached response to your Freedom of Information/Privacy Act request #20-00422-F. If you have any questions, please contact me at (571) 776-3247.

Thank you,

Cynthia Chasten
Government Information Specialist
Processing Unit
Freedom of Information and Privacy Act Section
U.S. Drug Enforcement Administration
Tel: 571-776-3247
Email: Cynthia.M.Chasten@usdoj.gov<mailto:Cynthia.M.Chasten@usdoj.gov>

From: Drug Enforcement Administration

Good Morning Mr. Bing:

Please see the attached response to your Freedom of Information Act/Privacy Act request 20-00422-F.

If you have any questions, please contact me at the phone number or email address below.

Thanks,

Cynthia Chasten
Government Information Specialist
Processing Unit
Freedom of Information and Privacy Act Section
U.S. Drug Enforcement Administration
Tel: 571-776-3247
Email: Cynthia.M.Chasten@usdoj.gov<mailto:Cynthia.M.Chasten@usdoj.gov>

PRIVACY ACT INFORMATION: This e-mail may contain information that requires protection in compliance with the Privacy Act of 1974 (5 U.S.C. § 552a). If the reader of this communication is not the intended recipient, you are hereby notified that any dissemination, distribution, or copying of this communication is strictly prohibited. If this communication has been received in error, please immediately delete all copies and notify me by e-mail.

From: Drug Enforcement Administration

Good Afternoon Mr. Bing:

Please see the attached response to your Freedom of Information Act/Privacy Act request 20-00422-F.
If you have any questions, please contact me at the phone number or email address provided in the attached letter.

Thanks,

Cynthia Chasten
Government Information Specialist
Processing Unit
Freedom of Information and Privacy Act Section
U.S. Drug Enforcement Administration
Tel: 571-776-3247
Email: Cynthia.M.Chasten@usdoj.gov<mailto:Cynthia.M.Chasten@usdoj.gov>

PRIVACY ACT INFORMATION: This e-mail may contain information that requires protection in compliance with the Privacy Act of 1974 (5 U.S.C. § 552a). If the reader of this communication is not the intended recipient, you are hereby notified that any dissemination, distribution, or copying of this communication is strictly prohibited. If this communication has been received in error, please immediately delete all copies and notify me by e-mail.

Files

pages

Close